Cross Country Healthcare Beheer

Beheer criteriumcontroles 2/4

De CEO Cross Country Healthcare is John Martins, benoemd in Apr2022, heeft een ambtstermijn van 2.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 3.51M, bestaande uit 24.8% salaris en 75.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.47% van de aandelen van het bedrijf, ter waarde € 1.57M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.5 jaar en 5.2 jaar.

Belangrijke informatie

John Martins

Algemeen directeur

US$3.5m

Totale compensatie

Percentage CEO-salaris	24.8%
Dienstverband CEO	2.6yrs
Eigendom CEO	0.5%
Management gemiddelde ambtstermijn	3.5yrs
Gemiddelde ambtstermijn bestuur	5.2yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is John Martins's beloning veranderd ten opzichte van Cross Country Healthcare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$2m
Jun 30 2024	n/a	n/a	US$8m
Mar 31 2024	n/a	n/a	US$46m
Dec 31 2023	US$4m	US$869k	US$73m
Sep 30 2023	n/a	n/a	US$102m
Jun 30 2023	n/a	n/a	US$124m
Mar 31 2023	n/a	n/a	US$156m
Dec 31 2022	US$3m	US$647k	US$188m
Sep 30 2022	n/a	n/a	US$227m
Jun 30 2022	n/a	n/a	US$216m
Mar 31 2022	n/a	n/a	US$175m
Dec 31 2021	US$1m	US$397k	US$132m

Compensatie versus markt: De totale vergoeding ($USD 3.51M ) John } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 1.03M ).

Compensatie versus inkomsten: De vergoeding van John is gestegen terwijl het bedrijf verliesgevend is.

CEO

John Martins (56 yo)

2.6yrs

Tenure

US$3,511,756

Compensatie

Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.6m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.6m
William Burns	Executive VP & CFO	5.8yrs	US$1.50m	0.73% € 2.4m
Susan Ball	Chief Administrative Officer	20.5yrs	US$1.18m	0.53% € 1.8m
Marc Krug	Group President of Delivery	no data	US$953.25k	0.11% € 351.9k
James Redd	Senior VP & Chief Accounting Officer	2yrs	geen gegevens	0.056% € 186.1k
Phillip Noe	Chief Information Officer	3.5yrs	geen gegevens	0.031% € 102.5k
Joshua Vogel	Vice President of Investor Relations	2.7yrs	geen gegevens	geen gegevens
Karen Varga-Sinka	Director of Corporate Communications	no data	geen gegevens	geen gegevens
Gerald Purgay	Chief Marketing Officer	3.7yrs	geen gegevens	geen gegevens
Mark Fortunato	Vice President of Corporate Development	no data	geen gegevens	geen gegevens
Colin McDonald	Chief Human Resources Officer	no data	geen gegevens	0.074% € 244.5k

3.5yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van XXY wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.6m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.6m
Mark Perlberg	Independent Director	9.5yrs	US$240.00k	0.28% € 941.2k
W. Cash	Lead Independent Director	23.1yrs	US$268.75k	0.59% € 2.0m
Gale Fitzgerald	Independent Director	17.5yrs	US$237.25k	0.53% € 1.8m
Janice Nevin	Independent Director	4.5yrs	US$225.00k	0.10% € 339.1k
Dwayne Allen	Independent Director	1.8yrs	US$287.50k	0.045% € 149.2k
Venkat Bhamidipati	Independent Director	2yrs	US$231.25k	0.045% € 148.8k

5.2yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van XXY wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.2 jaar).

Cross Country Healthcare Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Insider recently sold €216k worth of stock

Chief Information Officer recently sold €126k worth of stock

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$0.077 (vs US$0.37 in 3Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Cross Country Healthcare, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insider recently sold €216k worth of stock

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.60 profit in 2Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 16%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold €126k worth of stock

First quarter 2024 earnings released: EPS: US$0.079 (vs US$0.82 in 1Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

New minor risk - Share price stability

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$2.07 (vs US$5.09 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued after recent price drop

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Investor sentiment deteriorates as stock falls 22%

Insider recently sold €122k worth of stock

Third quarter 2023 earnings released: EPS: US$0.37 (vs US$0.94 in 3Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: US$0.60 (vs US$1.41 in 2Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

First quarter 2023 earnings released: EPS: US$0.82 (vs US$1.67 in 1Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Full year 2022 earnings released: EPS: US$5.09 (vs US$3.60 in FY 2021)

Investor sentiment improves as stock rises 15%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.94 (vs US$0.63 in 3Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare, Inc. Terminates Employment of Buffy S. White as Group President, Workforce solutions

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. Revising Financial Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) has entered into a definitive agreement to acquire Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare Launches the New Crosscountry.Com

President recently bought €101k worth of stock

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) announces an Equity Buyback for $100 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$1.41 (vs US$0.32 in 2Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. Appoints Craig Hoven as Senior Vice President and Managing Consultant of Cejka Search

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Cross Country Healthcare, Inc.(NasdaqGS:CCRN) dropped from Russell 2000 Value-Defensive Index

First quarter 2022 earnings released: EPS: US$1.67 (vs US$0.54 in 1Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Cross Country Healthcare, Inc. to Report Q1, 2022 Results on May 04, 2022

Cross Country Healthcare Appoints Daniel J. White to New Chief Commercial Officer

Cross Country Healthcare, Inc., Annual General Meeting, May 17, 2022

Chief Administrative Officer recently sold €333k worth of stock